5 Novel FDA Approvals Notched in 2024
Source: Bio Space, January 2025
Among the 55 novel drugs that crossed the regulatory finish line last year were notable new mechanisms of action, coming particularly in the oncology and neurosciences spaces.
The FDA approved 55 novel medicines in 2024—some first-in-class and others representing the first new mechanism of action for an indication in decades.
Novel approvals last year ran the therapeutic gamut from cardiovascular and hematological to infectious diseases, with some of the most significant new mechanisms of action found in oncology and neuroscience.